Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.
Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y. Baron F, et al. Among authors: seidel l. J Hematol Oncol. 2015 Feb 6;8:4. doi: 10.1186/s13045-014-0098-9. J Hematol Oncol. 2015. PMID: 25652604 Free PMC article. Clinical Trial.
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Castermans E, Baron F, Willems E, Schaaf-Lafontaine N, Meuris N, Gothot A, Vanbellighen JF, Herens C, Seidel L, Geenen V, Cheynier R, Beguin Y. Castermans E, et al. Among authors: seidel l. Haematologica. 2008 Feb;93(2):240-7. doi: 10.3324/haematol.11708. Epub 2008 Jan 26. Haematologica. 2008. PMID: 18223286 Free article. Clinical Trial.
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.
Willems E, Baron F, Baudoux E, Wanten N, Seidel L, Vanbellinghen JF, Herens C, Gothot A, Frère P, Bonnet C, Hafraoui K, Vanstraelen G, Fillet G, Beguin Y. Willems E, et al. Among authors: seidel l. Leukemia. 2009 Mar;23(3):608-10. doi: 10.1038/leu.2008.248. Epub 2008 Sep 18. Leukemia. 2009. PMID: 18800147 Free article. Clinical Trial. No abstract available.
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y. Baron F, et al. Among authors: seidel l. Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28. Biol Blood Marrow Transplant. 2010. PMID: 20109568 Free article. Clinical Trial.
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.
Castermans E, Hannon M, Dutrieux J, Humblet-Baron S, Seidel L, Cheynier R, Willems E, Gothot A, Vanbellinghen JF, Geenen V, Sandmaier BM, Storb R, Beguin Y, Baron F. Castermans E, et al. Among authors: seidel l. Haematologica. 2011 Feb;96(2):298-306. doi: 10.3324/haematol.2010.029702. Epub 2010 Oct 7. Haematologica. 2011. PMID: 20934996 Free PMC article.
285 results